About this trial
This study will be conducted as a randomized controlled pre-test post-test study to determine the effects of technology-based complementary feeding training given to mothers during the transition period of babies to complementary feeding on babies' behavior and development and their mothers' anxiety levels.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Transition to traditional complementary feeding
BehavioralFive-month-old babies in the complementary feeding phase will be identified. Before starting the training, mothers will fill out an introductory information form for their babies. Anthropometric measurements of the babies will be taken by the researcher. Mothers will be administered an anxiety scale and a complementary feeding transition behavior scale. The Denver II screening test will be administered to the babies. Then, the mothers of these babies will be registered in the web-based training system. Training modules will be uploaded to the system according to months. Mothers will complete these training modules. At the end of the training, the anxiety scale will be administered to the mothers again. The Denver II screening test will be administered to the babies again at 9 months.
Treatment groups
Trial outcomes
Primary outcomes
Infants' transition to complementary feeding
The infants' transition to complementary feeding will be measured using the 'Complementary Feeding Transition Behavior Scale'.
Secondary outcomes
Growth and development of babies during the transition to complementary feeding.
Anthropometric measurements will be taken of the babies at 6 and 9 months. The babies' development will be evaluated twice, at the beginning and end of the study, using the Denver II Developmental Screening Test, for which an application certificate is obtained.
Other outcomes
Mothers' anxiety levels during the transition to complementary feeding for their babies
The 'State-Trait Anxiety Scale' will be administered to the mothers of the infants at the beginning and end of the study.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: